RecruitingNot ApplicableNCT05556902

Therapeutic Mechanisms of Epidural Spinal Cord Stimulation


Sponsor

University of Alabama at Birmingham

Enrollment

80 participants

Start Date

Aug 2, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study in patients undergoing routine care epidural spinal cord stimulation (SCS) is to determine 1) whether SCS reduces arterial blood pressure (BP) in patients which chronic low back pain and hypertension, 2) whether higher baseline BP (i.e., hypertension) predicts reductions in pain following SCS, and finally 3) whether different SCS waveforms elicits stimulus-evoked compound action potentials (ECAPs) in spinal cord and at the cortex (electroencephalography, and magnetoenchphalography).


Eligibility

Min Age: 18 YearsMax Age: 89 Years

Inclusion Criteria5

  • Male or Female, age 18-89
  • Chronic pain for more than 3 months
  • Willing to visit a research lab
  • Willing to undergo a blood draw
  • Able to provide written informed consent

Exclusion Criteria4

  • History of neurological disease (e.g., dementias, Parkinson's)
  • History of stroke
  • Current diagnosis of cancer
  • Subject is unwilling or unable to comply with the protocol

Interventions

DEVICEPermanent Epidural Spinal Cord Stimulation

Permanent Spinal Cord Stimulation implanted in participants undergoing routine care for management of chronic neuropathic pain.


Locations(1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05556902


Related Trials